Genetic diversity and pathogenic variants as possible predictors of severity in a French sample of nonsyndromic heritable thoracic aortic aneurysms and dissections (nshTAAD)

Archive ouverte

Arnaud, Pauline | Hanna, Nadine | Benarroch, Louise | Aubart, Mélodie | Bal, Laurence | Bouvagnet, Patrice | Busa, Tiffany | Dulac, Yves | Dupuis-Girod, Sophie | Edouard, Thomas | Faivre, Laurence | Gouya, Laurent | Lacombe, Didier | Langeois, Maud | Leheup, Bruno | Milleron, Olivier | Naudion, Sophie | Odent, Sylvie | Tchitchinadze, Maria | Ropers, Jacques | Jondeau, Guillaume | Boileau, Catherine

Edité par CCSD ; Nature Publishing Group -

International audience. Purpose : Heritable thoracic aortic aneurysms and dissections (hTAAD) are life-threatening complications of well-known syndromic diseases or underdiagnosed nonsyndromic heritable forms (nshTAAD). Both have an autosomal dominant transmission and are genetically heterogeneous. Our objective was to describe the relevance of molecular diagnosis in these patients and the contribution of each gene in nshTAAD. Methods : Two hundred twenty-six consecutive nshTAAD probands, either young (<45 years) sporadic or familial cases were included. A next-generation sequencing capture panel comprising 23 known disease-causing genes was performed. Results : Class 4 or 5 variants were identified in 18% of the nshTAAD probands, while class 3 variants were found in 10% of them. The yield in familial cases was greater than in sporadic cases. SMAD3 and FBN1 genes were the major disease-causing genes. Unexpectedly, no premature termination codon variant was identified in the FBN1 gene. Furthermore, we report for the first time that aortic dissection or surgery occurred significantly more often and earlier in probands with a class 4 or 5 pathogenic variant. Conclusion : This study indicates that genetic screening using NGS is efficient in young and familial nshTAAD. The presence of a pathogenic variant has a possible predictive value, which needs to be further investigated because it may influence care.

Consulter en ligne

Suggestions

Du même auteur

Homozygous and compound heterozygous mutations in the FBN1 gene: unexpected findings in molecular diagnosis of Marfan syndrome

Archive ouverte | Arnaud, Pauline | CCSD

IF 5.451. International audience. Background Marfan syndrome (MFS) is an autosomal-dominant connective tissue disorder usually associated with heterozygous mutations in the gene encoding fibrillin-1 (FBN1). Homozygo...

PFMG2025–integrating genomic medicine into the national healthcare system in France

Archive ouverte | Abadie, Caroline | CCSD

International audience. Integrating genomic medicine into healthcare systems is a health policy challenge that requires continuously transferring scientific advances into clinics and ensuring equal access for patien...

Marfan Sartan: a randomized, double-blind, placebo-controlled trial

Archive ouverte | Milleron, Olivier | CCSD

International audience. Aims - To evaluate the benefit of adding Losartan to baseline therapy in patients with Marfan syndrome (MFS). Methods and results - A double-blind, randomized, multi-centre, placebo-controll...

Chargement des enrichissements...